Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President and CEO

Chief Financial Officer

PRESIDENT AND CEO

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which is in Phase 3 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-11-20	Premium	acquired	Premium	Premium	Premium	-
2023-11-20	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-04-24	Premium	gifted	Premium	Premium	Premium	President and CEO
2023-04-07	Premium	acquired	Premium	Premium	Premium	-
2023-04-07	Premium	acquired	Premium	Premium	Premium	President and CEO
2023-04-07	Premium	acquired	Premium	Premium	Premium	-
2023-04-07	Premium	acquired	Premium	Premium	Premium	-
2023-04-07	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2023-04-07	Premium	acquired	Premium	Premium	Premium	-
2023-02-06	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-01-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2022-01-04	Premium	acquired	Premium	Premium	Premium	-
2022-01-04	Premium	sold (taxes)	Premium	Premium	Premium	-
2021-12-20	Premium	gifted	Premium	Premium	Premium	President and CEO
2021-10-12	Premium	bought	Premium	Premium	Premium	-

ANVS - Annovis Bio Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ANVS